|
From: OncLive <edigest@onclive.com>
Sent: <Day, Month xx, 2020>
To: <<Email Address>>
Subject: Live Broadcast Registration Reminder: A New Combination for Advanced Renal Cell Carcinoma
No Images? Click here
|
|
|
Dear [Full Name],
This is a reminder that you have registered to view this Live Broadcast to gain an expert perspective on the changing therapeutic landscape and learn about a new combination approach for patients with advanced renal cell carcinoma.
Thank you for your participation!
Date: [Month/Day/20]
Time: [XX:XXpm]
|
|
|
This program is intended for US Healthcare Professionals including: Oncologists, NPs, PAs, RNs, Pharmacists. Program is not intended for non-healthcare professionals, including guests or spouses.
|
|
|
|
|
[Fullname, Credentials]
[Faculty Title]
[Faculty Institution]
[Faculty City, State]
|
|
|
|
[Fullname, Credentials]
[Faculty Title]
[Faculty Institution]
[Faculty City, State]
|
|
|
|
[Fullname, Credentials]
[Faculty Title]
[Faculty Institution]
[Faculty City, State]
|
|
|
|
In this Live Broadcast [expert, expert and expert] will:
|
|
|
|
|
Review mechanisms of action of a multitargeted approach to aRCC treatment
|
|
|
|
|
|
Explore key efficacy and safety data for a new combination regimen
|
|
|
|
|
|
Provide expert perspectives on clinical trial data
|
|
|
|
|
|
Share clinical insights through a live Q&A
|
|
|
|
|
|
|
CA-1715 09/20
This program is not certified for Continuing Medical Education credit.
This program is intended for US Healthcare Professionals including: Oncologists, NPs, PAs, RNs, Pharmacists. Program is not intended for non-healthcare professionals, including guests or spouses.
|
|
|
|
|
|
OncLive® – an MJH Life Sciences™ brand
Copyright 2020 © Intellisphere, LLC
2 Clarke Dr | Suite 100 | Cranbury, NJ | 08512
Preferences | Unsubscribe
|
|
|
